2026 NPPES data Research Study Specialist NPI 1407091010 MD
Verify on CMS →

AMIR-MOHAMMAD JALILIAN-NOSRATY, MD

Research Study Specialist in SANTA BARBARA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 282 beneficiaries · Research Study Specialist avg: 601
What the federal data reveals: AMIR-MOHAMMAD JALILIAN-NOSRATY, MD is a Research Study Specialist ([object Object]) practicing in SANTA BARBARA, California with a Medicare Part D prescribing footprint of 1K claims across 282 beneficiaries .

What stands out: AMIR-MOHAMMAD JALILIAN-NOSRATY, MD filed 1,193 Medicare Part D claims in 2023 across SANTA BARBARA, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

AMIR-MOHAMMAD JALILIAN-NOSRATY, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 12/10/2008

NPI 1407091010

Primary specialty

Research Study Specialist

Rare

472 US NPIs in this specialty

Medicare Part D claims

1,193 99% vs specialty avg

2023 prescription claims

Specialty avg: 601

Specialty distribution in California

How Research Study Specialist compares to other specialties among California providers

California providers

Research Study Specialist share within California

1. Research Study Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Research Study Specialist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Research Study Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Research Study Specialist ABMS/AOA estimate

Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMIR-MOHAMMAD JALILIAN-NOSRATY, MD is a Research Study Specialist provider practicing in SANTA BARBARA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1407091010. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AMIR-MOHAMMAD JALILIAN-NOSRATY, MD appears in the CMS NPPES registry as a Research Study Specialist provider holding MD credentials at 517 W JUNIPERO ST, SANTA BARBARA, CA, 93105, with a listed phone of (805) 682-8844. NPI 1407091010 was issued on 12/10/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JALILIAN-NOSRATY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,193 prescription claims written by this provider, covering 282 Medicare beneficiaries and totaling roughly $98K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Research Study Specialist is a narrow specialty nationwide, with 472 enrolled providers across 41 states and an average of 601 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

517 W JUNIPERO ST
SANTA BARBARA, CA 93105

Provider Details

NPI 1407091010
Specialty Research Study Specialist
Credentials MD
Gender Male
NPI Issued 12/10/2008

Hospital and facility affiliations

Facilities where AMIR-MOHAMMAD JALILIAN-NOSRATY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COTTAGE CLINICAL ASSOCIATES
GOLETA, CA
COTTAGE MEDICAL FOUNDATION
GOLETA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to AMIR-MOHAMMAD JALILIAN-NOSRATY, MD. To verify AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,193
Total Claims
$98K
Total Drug Cost
282
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,447
Total Day Supply
71,411
Generic Drug Cost
$23K
Antibiotic Claims
22

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
1.24
Gender Split
47% female / 53% male
Age Distribution
<65: 38, 65-74: 146, 75-84: 75, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
118
Amlodipine Besylate
78
Levothyroxine Sodium
66
Losartan Potassium
62
Lisinopril
59
Hydrochlorothiazide
37
Metformin Hcl
37
Gabapentin
30
Omeprazole
28
Tamsulosin Hcl
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Research Study Specialist Overview

How AMIR-MOHAMMAD JALILIAN-NOSRATY, MD fits within the Research Study Specialist landscape nationally.

472
Research Study Specialist Providers in US
41
States with Research Study Specialist
601
Avg Claims per Provider

AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's 1,193 claims are above the specialty average of 601.

Nearby Research Study Specialist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as JALILIAN-NOSRATY.

Compare Research Study Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's specialty?
AMIR-MOHAMMAD JALILIAN-NOSRATY, MD specializes in Research Study Specialist and practices in SANTA BARBARA, California. Credentials: MD.
How much does AMIR-MOHAMMAD JALILIAN-NOSRATY, MD prescribe under Medicare Part D?
In 2023, AMIR-MOHAMMAD JALILIAN-NOSRATY, MD wrote 1,193 Medicare Part D claims totaling $98K in drug costs for 282 beneficiaries.
Where is AMIR-MOHAMMAD JALILIAN-NOSRATY, MD located?
AMIR-MOHAMMAD JALILIAN-NOSRATY, MD is located at 517 W JUNIPERO ST, SANTA BARBARA, CA, 93105. Phone: (805) 682-8844.
What is AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's NPI number?
AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's National Provider Identifier (NPI) is 1407091010, issued on 12/10/2008.
How many Research Study Specialist providers are there in the US?
There are 472 Research Study Specialist providers across 41 states in the US. The average Research Study Specialist provider writes 601 Medicare Part D claims per year.
What drugs does AMIR-MOHAMMAD JALILIAN-NOSRATY, MD prescribe most often?
Based on 2023 Medicare Part D data, AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's most frequently prescribed drugs include Atorvastatin Calcium, Amlodipine Besylate, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMIR-MOHAMMAD JALILIAN-NOSRATY, MD accept Medicare?
AMIR-MOHAMMAD JALILIAN-NOSRATY, MD appears in CMS Medicare data with 1,193 Part D claims and 282 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's credentials?
AMIR-MOHAMMAD JALILIAN-NOSRATY, MD's NPI is 1407091010 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology